NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT02331251 2018-07-02Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Western Regional Medical CenterPhase 1/2 Terminated81 enrolled